{"id":2137,"date":"2024-07-29T14:39:22","date_gmt":"2025-10-07T12:54:24","guid":{"rendered":"https:\/\/www.elixirr.com\/en-us\/?post_type=case_study&#038;p=2137"},"modified":"2025-11-25T12:07:53","modified_gmt":"2025-11-25T12:07:53","slug":"beigene-increasing-global-access-to-cancer-treatments","status":"publish","type":"case_study","link":"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/","title":{"rendered":"BeiGene: increasing global access to cancer treatments"},"content":{"rendered":"<section\n    class=\"wp-block-text-block edwp-block layout--spacing-y bg--none\"\n    >\n    <div class=\"wp-block-text-block__container container fade-in\">\n        <div class=\"wp-block-text-block__content wysiwyg\">\n            <p class=\"meta-right-overview\">BeiGene, a global biotechnology company, is dedicated to improving access to high-quality cancer treatments worldwide. By focusing on innovative drugs, diverse clinical trials, and in-house capabilities, BeiGene aims to address global cancer challenges and enhance health equity.<\/p>\n<div class=\"hero-meta\">\n<ul class=\"meta-list\">\n<li>Outcome 1: Expanded access to innovative cancer treatments in over 50 countries<\/li>\n<li>Outcome 2: Achieved 90% in-house clinical trials, reducing time and costs by one-third<\/li>\n<li>Outcome 3: Enhanced patient diversity in clinical trials, representing various demographics and economic levels<\/li>\n<\/ul>\n<\/div>\n        <\/div>\n            <\/div>\n<\/section>\n\n\n<section\n    class=\"wp-block-banner edwp-block layout--spacing-y bg--secondary wp-block-banner--content-right\"\n    >\n    <div class=\"container wp-block-banner__container\">\n        <div class=\"edwp-component edwp-fade-in wp-block-banner__content\">\n            <h2 class=\"wp-component-heading wp-component-content__title text--h1\">\n    The challenge<\/h2>                <div class=\"wp-component-content__content wp-component-content__content--cols-1 wysiwyg\">\n                            <div class=\"wp-component-content__column\">\n                    <div class=\"case-study-challenge-block\">\n<p><span lang=\"EN-US\">Cancer incidence and mortality are increasing globally, with significant disparities in access to high-quality care. In the U.S., over 600,000 cancer-related deaths are projected annually, while in China, about 55 people die from cancer every 10 minutes. Founded over a decade ago, BeiGene aims to address these challenges by developing and distributing innovative cancer treatments worldwide. With 16 drugs available in China and more globally, including Brukinsa, the first anti-cancer drug from China approved by the FDA, BeiGene, is committed to improving access and affordability of cancer care.<\/span><\/p>\n<p><span lang=\"EN-US\">Many cancer patients worldwide lack access to necessary therapies, with roughly a quarter of patients not receiving the treatments they need. BeiGene faced the challenge of expanding access to its innovative treatments while ensuring diverse participation in clinical trials. Additionally, the company needed to enhance its internal capabilities for conducting clinical trials to reduce reliance on external CROs, cut costs, and expedite patient enrollment in trials.<\/span><\/p>\n<\/div>\n                <\/div>\n                    <\/div>\n                    <\/div>            <\/div>\n<\/section>\n\n\n<section\n    class=\"wp-block-banner edwp-block layout--none bg--secondary wp-block-banner--content-right\"\n    >\n    <div class=\"container wp-block-banner__container\">\n        <div class=\"edwp-component edwp-fade-in wp-block-banner__content\">\n            <h2 class=\"wp-component-heading wp-component-content__title text--h1\">\n    The approach<\/h2>                <div class=\"wp-component-content__content wp-component-content__content--cols-1 wysiwyg\">\n                            <div class=\"wp-component-content__column\">\n                    <p>Under the leadership of BeiGene\u2019s global head of clinical operations, the company prioritized patient diversity in clinical trials, focusing on data and analytics to create a cross-functional initiative. The company worked closely with health authorities, ethics committees and clinical sites to expand its global footprint. By integrating clinical trial capabilities in-house, BeiGene improved the patient experience and reduced time and costs associated with trials by one-third. The holistic infrastructure includes regulatory and medical affairs, human resources, legal, finance, and other fields, ensuring a comprehensive approach to clinical trials.<\/p>\n                <\/div>\n                    <\/div>\n                    <\/div>            <\/div>\n<\/section>\n\n\n<section\n    class=\"wp-block-banner edwp-block layout--spacing-y bg--secondary wp-block-banner--content-right\"\n    >\n    <div class=\"container wp-block-banner__container\">\n        <div class=\"edwp-component edwp-fade-in wp-block-banner__content\">\n            <h2 class=\"wp-component-heading wp-component-content__title text--h1\">\n    The value delivered<\/h2>                <div class=\"wp-component-content__content wp-component-content__content--cols-1 wysiwyg\">\n                            <div class=\"wp-component-content__column\">\n                    <section id=\"case-study-challenge-block_3b5f03cd3f5e193a18d4c051b6b0389a\" class=\"case-study-challenge page-width\">\n<div class=\"case-study-challenge-block\">\n<p>BeiGene\u2019s approach significantly increased global access to cancer treatments, with Brukinsa now available in over 50 countries. The company\u2019s focus on diversity in clinical trials has ensured that participants represent various demographics and economic levels, leading to more inclusive and representative research. By bringing clinical trial capabilities in-house, BeiGene has enhanced efficiency, allowing quicker patient enrollment and reducing costs.<\/p>\n<p>These efforts positioned BeiGene as a leader in delivering high-quality cancer care and addressing global health disparities, with a mission-driven strategy that prioritizes patient access over profit.<\/p>\n<\/div>\n<\/section>\n                <\/div>\n                    <\/div>\n                    <\/div>            <\/div>\n<\/section>\n\n\n<section\n    class=\"wp-block-testimonials-block edwp-block layout--spacing-y bg--none\"\n    >\n    <div class=\"wp-block-testimonials-block__container\">\n                <div class=\"wp-block-testimonials-block__content-wrapper\">\n                            <div class=\"wp-block-testimonials-block__testimonials-wrapper\">\n                <div class=\"wp-component-testimonials wp-block-testimonials-block__testimonials\">\n        <div class=\"swiper-wrapper wp-component-testimonials__swiper-wrapper\">\n                            <div class=\"swiper-slide wp-component-testimonials__slide js-wp-component-testimonials-slide\">\n                        <div class=\"wp-component-testimonial \">\n        <p class=\"wp-component-testimonial__quote\">\n            <svg class='edwp-icon edwp-icon--lrg js-icon wp-component-testimonial__quote-icon wp-component-testimonial__quote-icon-start' aria-hidden='true'>\n                <use xlink:href='#quote'><\/use>\n            <\/svg>We are humanitarians [and] our vocation is to focus on developing cancer medicines, and our work is to make sure that we bring those to our patients \u2014 no matter where they are. We transformed ourselves to go to global markets, but also expanding our current footprint in Australia, Europe, Latin America and the Asia-Pacific region.<svg class='edwp-icon edwp-icon--lrg js-icon wp-component-testimonial__quote-icon wp-component-testimonial__quote-icon-end' aria-hidden='true'>\n                <use xlink:href='#quote'><\/use>\n            <\/svg>        <\/p>\n                    <div class=\"wp-component-testimonial__cite\">\n                Melika Davis &#8211; SVP &amp; Global Head, Clinical Operations, BeiGene            <\/div>\n                    <\/div>\n                <\/div>\n                    <\/div>\n            <\/div>\n            <\/div>\n                <\/div>\n            <\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":55383,"template":"","related_service":[64],"related_industry":[44],"class_list":["post-2137","case_study","type-case_study","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>BeiGene: increasing global access to cancer treatments - Elixirr<\/title>\n<meta name=\"description\" content=\"BeiGene partnered with Elixirr to expand access to innovative cancer treatments in over 50 countries, increase trial diversity and cut trial costs by a third.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Case Studies\" \/>\n<meta property=\"og:description\" content=\"BeiGene partnered with Elixirr to expand access to innovative cancer treatments in over 50 countries, increase trial diversity and cut trial costs by a third.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/\" \/>\n<meta property=\"og:site_name\" content=\"Elixirr - USA\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-25T12:07:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"820\" \/>\n\t<meta property=\"og:image:height\" content=\"492\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/\",\"url\":\"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/\",\"name\":\"BeiGene: increasing global access to cancer treatments - Elixirr\",\"isPartOf\":{\"@id\":\"https:\/\/www.elixirr.com\/en-us\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature.jpg\",\"datePublished\":\"2025-10-07T12:54:24+00:00\",\"dateModified\":\"2025-11-25T12:07:53+00:00\",\"description\":\"BeiGene partnered with Elixirr to expand access to innovative cancer treatments in over 50 countries, increase trial diversity and cut trial costs by a third.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/#primaryimage\",\"url\":\"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature.jpg\",\"contentUrl\":\"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature.jpg\",\"width\":820,\"height\":492},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.elixirr.com\/en-us\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Case Studies\",\"item\":\"https:\/\/www.elixirr.com\/en-us\/case-studies\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"BeiGene: increasing global access to cancer treatments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.elixirr.com\/en-us\/#website\",\"url\":\"https:\/\/www.elixirr.com\/en-us\/\",\"name\":\"Elixirr - USA\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.elixirr.com\/en-us\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.elixirr.com\/en-us\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.elixirr.com\/en-us\/#organization\",\"name\":\"Elixirr\",\"alternateName\":\"Elixirr International PLC\",\"url\":\"https:\/\/www.elixirr.com\/en-us\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.elixirr.com\/en-us\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/11\/elixirr-logo.png\",\"contentUrl\":\"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/11\/elixirr-logo.png\",\"width\":200,\"height\":200,\"caption\":\"Elixirr\"},\"image\":{\"@id\":\"https:\/\/www.elixirr.com\/en-us\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"BeiGene: increasing global access to cancer treatments - Elixirr","description":"BeiGene partnered with Elixirr to expand access to innovative cancer treatments in over 50 countries, increase trial diversity and cut trial costs by a third.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/","og_locale":"en_US","og_type":"article","og_title":"Case Studies","og_description":"BeiGene partnered with Elixirr to expand access to innovative cancer treatments in over 50 countries, increase trial diversity and cut trial costs by a third.","og_url":"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/","og_site_name":"Elixirr - USA","article_modified_time":"2025-11-25T12:07:53+00:00","og_image":[{"width":820,"height":492,"url":"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/","url":"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/","name":"BeiGene: increasing global access to cancer treatments - Elixirr","isPartOf":{"@id":"https:\/\/www.elixirr.com\/en-us\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/#primaryimage"},"image":{"@id":"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature.jpg","datePublished":"2025-10-07T12:54:24+00:00","dateModified":"2025-11-25T12:07:53+00:00","description":"BeiGene partnered with Elixirr to expand access to innovative cancer treatments in over 50 countries, increase trial diversity and cut trial costs by a third.","breadcrumb":{"@id":"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/#primaryimage","url":"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature.jpg","contentUrl":"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature.jpg","width":820,"height":492},{"@type":"BreadcrumbList","@id":"https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.elixirr.com\/en-us\/"},{"@type":"ListItem","position":2,"name":"Case Studies","item":"https:\/\/www.elixirr.com\/en-us\/case-studies\/"},{"@type":"ListItem","position":3,"name":"BeiGene: increasing global access to cancer treatments"}]},{"@type":"WebSite","@id":"https:\/\/www.elixirr.com\/en-us\/#website","url":"https:\/\/www.elixirr.com\/en-us\/","name":"Elixirr - USA","description":"","publisher":{"@id":"https:\/\/www.elixirr.com\/en-us\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.elixirr.com\/en-us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.elixirr.com\/en-us\/#organization","name":"Elixirr","alternateName":"Elixirr International PLC","url":"https:\/\/www.elixirr.com\/en-us\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.elixirr.com\/en-us\/#\/schema\/logo\/image\/","url":"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/11\/elixirr-logo.png","contentUrl":"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/11\/elixirr-logo.png","width":200,"height":200,"caption":"Elixirr"},"image":{"@id":"https:\/\/www.elixirr.com\/en-us\/#\/schema\/logo\/image\/"}}]}},"card":"<article class=\"wp-component-card edwp-component wp-component-card--case_study            wp-component-card--link js-card-link\n        edwp-fade-in\">\n            <figure class=\"wp-component-card__image-wrapper\">\n                            <img width=\"820\" height=\"492\" src=\"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature.jpg\" class=\"wp-component-card__image\" alt=\"\" decoding=\"async\" srcset=\"https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature.jpg 820w, https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature-300x180.jpg 300w, https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature-768x461.jpg 768w, https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature-87x52.jpg 87w, https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature-319x191.jpg 319w, https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature-479x287.jpg 479w, https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature-567x340.jpg 567w, https:\/\/www.elixirr.com\/en-us\/wp-content\/uploads\/sites\/2\/2025\/10\/Bei-Gene-feature-767x460.jpg 767w\" sizes=\"(max-width: 820px) 100vw, 820px\" \/>            <div class=\"wp-component-card__preview-icon\">\n                <span class='edwp-svg '><svg width=\"47\" height=\"47\" viewBox=\"0 0 47 47\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n<g>\n<path d=\"M23.4141 0.539062C36.1232 0.539183 46.4258 10.8416 46.4258 23.5508C46.4257 36.2599 36.1231 46.5624 23.4141 46.5625C10.7049 46.5625 0.402465 36.2599 0.402344 23.5508C0.402344 10.8415 10.7048 0.539062 23.4141 0.539062ZM23.4141 1.68945C11.3606 1.68945 1.55273 11.4974 1.55273 23.5508C1.55286 35.6041 11.3607 45.4111 23.4141 45.4111C35.4673 45.411 45.2743 35.604 45.2744 23.5508C45.2744 11.4974 35.4674 1.68957 23.4141 1.68945Z\" fill=\"currentColor\"\/>\n<path d=\"M19.2841 33.6992C18.9579 33.6986 18.6374 33.6111 18.3543 33.4454C17.7167 33.0759 17.3203 32.3585 17.3203 31.5797V15.8189C17.3203 15.0379 17.7167 14.3227 18.3543 13.9531C18.6442 13.7827 18.9735 13.6951 19.3078 13.6994C19.6421 13.7037 19.9692 13.7998 20.2548 13.9776L33.4237 22.0406C33.6981 22.2166 33.9244 22.461 34.0812 22.751C34.238 23.0409 34.3203 23.3668 34.3203 23.6982C34.3203 24.0295 34.238 24.3555 34.0812 24.6454C33.9244 24.9353 33.6981 25.1798 33.4237 25.3558L20.2527 33.421C19.9604 33.6017 19.6256 33.6979 19.2841 33.6992Z\" fill=\"currentColor\"\/>\n<\/g>\n<\/svg>\n<\/span>            <\/div>\n                        <\/figure>\n        <div class=\"wp-component-card__content edwp-row-load\">\n                                    <p class=\"wp-component-card__eyebrow\">\n                Enterprise-Wide Transformation            <\/p>\n                <a href='https:\/\/www.elixirr.com\/en-us\/case-studies\/beigene-increasing-global-access-to-cancer-treatments\/' class='wp-component-card__title'>\n            <h2>\n                BeiGene: increasing global access to cancer treatments\n            <\/h2>\n        <\/a>                                                            <div class=\"wp-component-card__meta\">\n                                            <p class=\"wp-component-card__date\">\n                            29 July 2024                        <\/p>\n                                                                <div class=\"wp-component-card__terms\">\n                                                                                                                                                                                                                <div class=\"wp-component-tags edwp-component\">\n                        <div class=\"wp-component-tags__tag\">\n                Healthcare &amp; Pharmaceuticals            <\/div>\n                                <div class=\"wp-component-tags__tag\">\n                Enterprise-Wide Transformation            <\/div>\n                <\/div>\n                        <\/div>\n                                    <\/div>\n                                                    <div class=\"wp-component-card__button-wrapper\">\n                    <button class=\"btn btn--link arrow wp-component-card__button\">\n                                                                            Read more                                                                            <span class='edwp-svg '><svg width=\"20\" height=\"20\" viewBox=\"0 0 20 20\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n<g id=\"Lg\">\n<path id=\"Vector\" d=\"M1.12509 9.50162H15.8648L9.43259 3.06941C9.374 3.0113 9.3275 2.94216 9.29576 2.86599C9.26403 2.78981 9.24769 2.70811 9.24769 2.62559C9.24769 2.54307 9.26403 2.46137 9.29576 2.38519C9.3275 2.30902 9.374 2.23988 9.43259 2.18177C9.54971 2.06535 9.70814 2 9.87328 2C10.0384 2 10.1969 2.06535 10.314 2.18177L17.8151 9.6829C17.8737 9.74101 17.9202 9.81014 17.9519 9.88632C17.9837 9.96249 18 10.0442 18 10.1267C18 10.2092 17.9837 10.2909 17.9519 10.3671C17.9202 10.4433 17.8737 10.5124 17.8151 10.5705L10.314 18.0717C10.1975 18.1871 10.0404 18.2522 9.87641 18.2529C9.79414 18.2534 9.71259 18.2376 9.63643 18.2065C9.56027 18.1754 9.491 18.1296 9.43259 18.0717C9.374 18.0135 9.3275 17.9444 9.29576 17.8682C9.26403 17.7921 9.24769 17.7104 9.24769 17.6278C9.24769 17.5453 9.26403 17.4636 9.29576 17.3874C9.3275 17.3113 9.374 17.2421 9.43259 17.184L15.8711 10.7518H1.12509C0.959309 10.7518 0.800312 10.686 0.683084 10.5687C0.565857 10.4515 0.5 10.2925 0.5 10.1267C0.5 9.96093 0.565857 9.80193 0.683084 9.68471C0.800312 9.56748 0.959309 9.50162 1.12509 9.50162Z\" fill=\"#1D0F25\"\/>\n<\/g>\n<\/svg>\n<\/span>                                            <\/button>\n                <\/div>\n                                            <\/div>\n<\/article>\n","_links":{"self":[{"href":"https:\/\/www.elixirr.com\/en-us\/wp-json\/wp\/v2\/case_study\/2137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elixirr.com\/en-us\/wp-json\/wp\/v2\/case_study"}],"about":[{"href":"https:\/\/www.elixirr.com\/en-us\/wp-json\/wp\/v2\/types\/case_study"}],"author":[{"embeddable":true,"href":"https:\/\/www.elixirr.com\/en-us\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elixirr.com\/en-us\/wp-json\/wp\/v2\/media\/55383"}],"wp:attachment":[{"href":"https:\/\/www.elixirr.com\/en-us\/wp-json\/wp\/v2\/media?parent=2137"}],"wp:term":[{"taxonomy":"related_service","embeddable":true,"href":"https:\/\/www.elixirr.com\/en-us\/wp-json\/wp\/v2\/related_service?post=2137"},{"taxonomy":"related_industry","embeddable":true,"href":"https:\/\/www.elixirr.com\/en-us\/wp-json\/wp\/v2\/related_industry?post=2137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}